Concert Genetics and Trapelo Health Partner to Advance Molecular Oncology Decision Support Partnership Seeks to Lower Barriers to Evidence-Based Molecular Oncology Care by Extending Trapelo's Decision Support Solutions Through Concert's Network of Laboratories and Health Plans News provided by Share this article Share this article BURLINGTON, Mass. and NASHVILLE, Tenn., Dec. 10, 2020 /PRNewswire/ -- Concert Genetics and Trapelo Health announced today that they have partnered to provide a streamlined, integrated solution that will expand access to evidence-based, genomic-informed oncology dec...